OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tuberculosis vaccine development: from classic to clinical candidates
Junli Li, Aihua Zhao, Jun Tang, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2020) Vol. 39, Iss. 8, pp. 1405-1425
Open Access | Times Cited: 55
Junli Li, Aihua Zhao, Jun Tang, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2020) Vol. 39, Iss. 8, pp. 1405-1425
Open Access | Times Cited: 55
Showing 1-25 of 55 citing articles:
Of tuberculosis and non-tuberculous mycobacterial infections – a comparative analysis of epidemiology, diagnosis and treatment
Radha Gopalaswamy, Sivakumar Shanmugam, Rajesh Mondal, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 237
Radha Gopalaswamy, Sivakumar Shanmugam, Rajesh Mondal, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 237
Immunotherapies against human bacterial and fungal infectious diseases: A review
Hafsa Qadri, Abdul Haseeb Shah, Mustfa Alkhanani, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 24
Hafsa Qadri, Abdul Haseeb Shah, Mustfa Alkhanani, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 24
Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study
Artem P. Tkachuk, Evgeniia N. Bykonia, Liubov I. Popova, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 652-652
Open Access | Times Cited: 51
Artem P. Tkachuk, Evgeniia N. Bykonia, Liubov I. Popova, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 652-652
Open Access | Times Cited: 51
It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity
Sasha E. Larsen, Brittany D. Williams, Maham Rais, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Sasha E. Larsen, Brittany D. Williams, Maham Rais, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Advances in protein subunit vaccines against tuberculosis
Ying Zhang, Jinchuan Xu, Zhidong Hu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Ying Zhang, Jinchuan Xu, Zhidong Hu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
Junli Li, Lingjun Zhan, Chuan Qin
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 35
Junli Li, Lingjun Zhan, Chuan Qin
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 35
DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies
Alisa Kazakova, Pavel Zhelnov, Roman Yu. Sidorov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Alisa Kazakova, Pavel Zhelnov, Roman Yu. Sidorov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis
Chiara Bellini, Kata Horváti
Cells (2020) Vol. 9, Iss. 12, pp. 2673-2673
Open Access | Times Cited: 34
Chiara Bellini, Kata Horváti
Cells (2020) Vol. 9, Iss. 12, pp. 2673-2673
Open Access | Times Cited: 34
Optimizing antigen selection for the development of tuberculosis vaccines
Yang Yang, Yizhen Chen, Tian Xia
Cell Insight (2024) Vol. 3, Iss. 3, pp. 100163-100163
Open Access | Times Cited: 4
Yang Yang, Yizhen Chen, Tian Xia
Cell Insight (2024) Vol. 3, Iss. 3, pp. 100163-100163
Open Access | Times Cited: 4
Historical Examination of Tuberculosis; From Ancient Affliction to Modern Challenges
Seyyed Mohammad Amin Mousavi-Sagharchi, Atousa Ghorbani, Maryam Meskini, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102649-102649
Open Access
Seyyed Mohammad Amin Mousavi-Sagharchi, Atousa Ghorbani, Maryam Meskini, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102649-102649
Open Access
Protection against tuberculosis by vaccination of secreted chorismate mutase (Rv1885c) combined with a hepatitis B virus (HBV)-derived peptide, Poly6, and alum adjuvants
Hyejun Seo, Byungjun Kim, Jaehun Oh, et al.
Vaccine (2025) Vol. 47, pp. 126710-126710
Closed Access
Hyejun Seo, Byungjun Kim, Jaehun Oh, et al.
Vaccine (2025) Vol. 47, pp. 126710-126710
Closed Access
Overview of the tuberculosis vaccine development landscape Dr P.K.Sen TAI Gold medal oration
Banurekha Velayutham, V.V. Banu Rekha
Indian Journal of Tuberculosis (2025)
Closed Access
Banurekha Velayutham, V.V. Banu Rekha
Indian Journal of Tuberculosis (2025)
Closed Access
New Advances in the Development and Design of Mycobacterium tuberculosis Vaccines: Construction and Validation of Multi-Epitope Vaccines for Tuberculosis Prevention
Osnat Barazani, T. Erdös, RajibGon Chowdhury, et al.
Biology (2025) Vol. 14, Iss. 4, pp. 417-417
Open Access
Osnat Barazani, T. Erdös, RajibGon Chowdhury, et al.
Biology (2025) Vol. 14, Iss. 4, pp. 417-417
Open Access
Characterizing TLR4 agonist EmT4™ as an anti-Mycobacterium tuberculosis vaccine adjuvant
Sasha E. Larsen, Maham Rais, Valerie A. Reese, et al.
ImmunoHorizons (2025) Vol. 9, Iss. 6
Open Access
Sasha E. Larsen, Maham Rais, Valerie A. Reese, et al.
ImmunoHorizons (2025) Vol. 9, Iss. 6
Open Access
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants
Ana Rita Franco, Francesco Peri
Cells (2021) Vol. 10, Iss. 1, pp. 78-78
Open Access | Times Cited: 26
Ana Rita Franco, Francesco Peri
Cells (2021) Vol. 10, Iss. 1, pp. 78-78
Open Access | Times Cited: 26
Goals and strategies in vaccine development against tuberculosis
Bidyarani Devi Konjengbam, Heikrujam Nilkanta Meitei, Anupama Pandey, et al.
Molecular Immunology (2025) Vol. 183, pp. 56-71
Closed Access
Bidyarani Devi Konjengbam, Heikrujam Nilkanta Meitei, Anupama Pandey, et al.
Molecular Immunology (2025) Vol. 183, pp. 56-71
Closed Access
Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis
Nitin Verma, Vimal Arora, Rajendra Awasthi, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 75, pp. 103690-103690
Closed Access | Times Cited: 16
Nitin Verma, Vimal Arora, Rajendra Awasthi, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 75, pp. 103690-103690
Closed Access | Times Cited: 16
Self-adjuvanting nanovaccines boost lung-resident CD4+ T cell immune responses in BCG-primed mice
Megan Files, Kubra F. Naqvi, Taís B. Saito, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Megan Files, Kubra F. Naqvi, Taís B. Saito, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Computational approaches in epitope design using DNA binding proteins as vaccine candidate in Mycobacterium tuberculosis
SUNITA SUNITA, Nirjara Singhvi, Yogendra Singh, et al.
Infection Genetics and Evolution (2020) Vol. 83, pp. 104357-104357
Closed Access | Times Cited: 19
SUNITA SUNITA, Nirjara Singhvi, Yogendra Singh, et al.
Infection Genetics and Evolution (2020) Vol. 83, pp. 104357-104357
Closed Access | Times Cited: 19
Nanomaterials in tuberculosis DNA vaccine delivery: historical perspective and current landscape
Xing Luo, Xiaoqiang Zeng, L. Gong, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2912-2924
Open Access | Times Cited: 10
Xing Luo, Xiaoqiang Zeng, L. Gong, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2912-2924
Open Access | Times Cited: 10
Mycobacterium tuberculosis dormancy regulon proteins Rv2627c and Rv2628 as Toll like receptor agonist and as potential adjuvant
Parul Bhatt, Monika Sharma, Prem Prakash Sharma, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109238-109238
Closed Access | Times Cited: 10
Parul Bhatt, Monika Sharma, Prem Prakash Sharma, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109238-109238
Closed Access | Times Cited: 10
Immunoinformatics analysis of antigenic epitopes and designing of a multi-epitope peptide vaccine from putative nitro-reductases of Mycobacterium tuberculosis DosR
Mohd. Shiraz, Surabhi Lata, Pankaj Kumar, et al.
Infection Genetics and Evolution (2021) Vol. 94, pp. 105017-105017
Closed Access | Times Cited: 14
Mohd. Shiraz, Surabhi Lata, Pankaj Kumar, et al.
Infection Genetics and Evolution (2021) Vol. 94, pp. 105017-105017
Closed Access | Times Cited: 14
Enhancement of the Local CD8+ T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens
Kirill Vasilyev, Anna-Polina Shurygina, Natalia Zabolotnykh, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1273-1273
Open Access | Times Cited: 14
Kirill Vasilyev, Anna-Polina Shurygina, Natalia Zabolotnykh, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1273-1273
Open Access | Times Cited: 14
A tuberculosis model with early and late latency, imperfect vaccination, and relapse: An application to China
Qian Jiang, Zhijun Liu, Lianwen Wang, et al.
Mathematical Methods in the Applied Sciences (2023) Vol. 46, Iss. 9, pp. 10929-10946
Closed Access | Times Cited: 4
Qian Jiang, Zhijun Liu, Lianwen Wang, et al.
Mathematical Methods in the Applied Sciences (2023) Vol. 46, Iss. 9, pp. 10929-10946
Closed Access | Times Cited: 4
Construction and evaluation of a novel multi-antigenic Mycobacterium tuberculosis subunit vaccine candidate BfrB-GrpE/DPC
Hongxia Niu, Qianqian Cao, Tingting Zhang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 111060-111060
Closed Access | Times Cited: 4
Hongxia Niu, Qianqian Cao, Tingting Zhang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 111060-111060
Closed Access | Times Cited: 4
